Changeflow GovPing Healthcare Multi-Channel Automatic Infusion Valve for Surg...
Routine Notice Added Final

Multi-Channel Automatic Infusion Valve for Surgical Fluid Control

Favicon for changeflow.com USPTO Patent Applications - Medical Devices (A61M)
Published
Detected
Email

Summary

USPTO published patent application US20260096923A1 for a multi-channel automatic infusion valve designed for surgical fluid control. The invention includes a valve body with multiple conduits and ports, a hydrophobic filter extending across a cavity, and an activation member for managing fluid delivery and aspiration during medical procedures.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO published patent application US20260096923A1 for a multi-channel automatic infusion valve comprising a valve body with first and second conduits defining multiple ports, a cavity with a hydrophobic filter, and an activation member for surgical fluid control.

Medical device manufacturers developing infusion or fluid control systems should review the patent claims to assess potential infringement exposure or licensing opportunities for surgical valve technology.

What to do next

  1. Monitor for patent issuance and evaluate potential licensing needs

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

MULTI-CHANNEL AUTOMATIC INFUSION VALVE

Application US20260096923A1 Kind: A1 Apr 09, 2026

Inventors

Kevin CANZONE, Jonathan MOREIRA, Behzad HASHEMI

Abstract

The present disclosure generally relates to fluid control valves for delivering and/or aspirating fluid during surgical surgeries and procedures. In one embodiment, an apparatus comprises a valve body comprising a first conduit defining a first port, and a second conduit defining a second port and a third port. A cavity is defined in the valve body between the first conduit and the second conduit. The cavity is fluidly coupled with the first conduit via a first channel having a smaller diameter, and with the second conduit via at least one second channel. The apparatus further comprises a hydrophobic filter attached to the valve body and extending substantially across the cavity. The apparatus further comprises an activation member disposed in the cavity and defining one or more openings extending from a first side of the activation member contacting the hydrophobic filter, to an opposing second side facing the second conduit.

CPC Classifications

A61F 9/0017 A61M 39/223 A61M 39/227 A61M 2039/0009 A61M 2202/0007 A61M 2202/04 A61M 2205/3331 A61M 2205/7536 A61M 2206/10 A61M 2210/0612

Filing Date

2025-10-06

Application No.

19351080

View original document →

Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260096923A1

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent filing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!